[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100502777":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":91,"collaborators":93,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":103,"acronym":10,"eligibilityCriteria":104,"healthyVolunteers":101,"sex":105,"minAge":106,"maxAge":107,"enrollmentInfo":108,"targetDuration":10,"studyType":111,"phases":10,"briefSummary":112,"conditions":113,"keywords":10,"overallStatus":54,"whyStopped":10,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Kansas City Heart Rhythm Research Foundation","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"STAR Apollo Mapping System Group",null,"Patients who have been referred for persistent AF catheter ablation, who have already had AF recurrence post Pulmonary Vein Isolation (PVI), will be considered for this study.",[13],"Other: Persistent AF ablation assisted with the STAR Apollo Mapping System",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Persistent AF ablation assisted with the STAR Apollo Mapping System","This exploratory hypothesis generating data set will be collected during standard AF ablation procedures using FDA cleared technologies as described in their Instructions for Use (IFU). No randomization or experimental protocols will be used during this study, and all follow up will be performed as per the center's standard of care(SOC).",[9],[20],{"name":21,"affiliation":22,"role":23},"Dhanunjaya Lakkireddy, MD","Kansas City Heart Rhythm Institute","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Donita Atkins","CONTACT","816-651-1969","datkins@kchrf.com",[31,52,69,83],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"St.Bernards Medical Center","NOT_YET_RECRUITING","Jonesboro","Arkansas","72401","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-90.70428,35.8423,{"lat":43,"lon":42},[46,48],{"name":47,"role":27,"phone":10,"phoneExt":10,"email":10},"Devi Nair, MD",{"name":49,"role":27,"phone":50,"phoneExt":10,"email":51},"Kayla Rubino","870-9356-729","krubino@dnairresearch.com",{"facility":53,"status":54,"city":55,"state":56,"zip":57,"country":37,"countryCode":38,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Sarasota Medical Center","RECRUITING","Sarasota","Florida","34239",{"type":40,"coordinates":59},[60,61],-82.53065,27.33643,{"lat":61,"lon":60},[64,66],{"name":65,"role":27,"phone":10,"phoneExt":10,"email":10},"Dilip Matthew, MD",{"name":67,"role":27,"phone":10,"phoneExt":10,"email":68},"Colleen Lindner","colleen-lindner@smh.com",{"facility":70,"status":33,"city":71,"state":72,"zip":73,"country":37,"countryCode":38,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Kansas City Heart Rhythm Institute - Roe Clinic","Overland Park","Kansas","66211",{"type":40,"coordinates":75},[76,77],-94.67079,38.98223,{"lat":77,"lon":76},[80],{"name":21,"role":27,"phone":81,"phoneExt":10,"email":82},"913-449-1297","dlakkireddy@gmail.com",{"facility":84,"status":54,"city":71,"state":72,"zip":85,"country":37,"countryCode":38,"cosmosGeoPoint":86,"geoPoint":88,"contacts":89},"Overland Park Regional Medical Center","66215",{"type":40,"coordinates":87},[76,77],{"lat":77,"lon":76},[90],{"name":26,"role":27,"phone":10,"phoneExt":10,"email":10},{"type":92,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[94,95,98],{"name":22,"class":6},{"name":96,"class":97},"St. Bernards Medical Center","UNKNOWN",{"name":53,"class":97},"100502777","observational-study-to-examine-the-procedural-and-outcomes-of-af-ablation-assisted-by-star-apollo-mapping-system-100502777",false,"NCT05826665","Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System","Inclusion Criteria:\n\n* Indication for ablation of persistent AF\n* Age \\>18 years\n* Persistent AF \\>7 days and total continuous duration \\\u003C2 years\n* Patients have previously undergone pulmonary vein isolation, using any technique and have had AF recurrence.\n* Patients have limited additional ablation at their first procedure (e.g. right atrial flutter line).\n\nExclusion Criteria:\n\n* Patients with previous ablation in more than one region of the left atrium in addition to the pulmonary veins.\n* Patients with longstanding persistent AF (continuous duration \\>2 years) or significant substrate (mitral valve disease, scarring, very dilated atria \\>50mm).\n* Creatinine clearance estimated glomerular filtration rate (eGFR) \\\u003C30mls\u002Fmin\n* Contraindication to anticoagulation","ALL","18 Years","80 Years",{"count":109,"type":110},200,"ESTIMATED","OBSERVATIONAL","STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.",[114],"Persistent Atrial Fibrillation","2024-10-14",{"date":117,"type":118},"2024-10-16","ACTUAL",{"date":120,"type":118},"2023-10-02",{"date":122,"type":110},"2025-07-31",{"name":5,"class":6},4]